Thomas Trimarchi - 16 Nov 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
President and COO
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
16 Nov 2024
Net transactions value
-$425,442
Form type
4
Filing time
19 Nov 2024, 18:13:27 UTC
Previous filing
20 Aug 2024
Next filing
12 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Tax liability $425,442 -17,936 -4.5% $23.72 377,987 16 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,432 shares of Common Stock underlying the Reporting Person's restricted stock units.